{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:13:18Z","timestamp":1795029198930,"version":"4.10.2"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017596","name":"Natural Science Basic Research Program of Shaanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Osteoclast is a hematopoietic precursor cell derived from the mononuclear macrophage cell line, which is the only cell with bone resorption function. Its abnormal activation can cause serious osteolysis related diseases such as rheumatoid arthritis, Paget\u2019s disease and osteoporosis. In recent years, the adverse effects caused by anabolic anti-osteolytic drugs have increased the interest of researchers in the potential therapeutic and preventive effects of natural plant derivatives and natural compounds against osteolytic diseases caused by osteoclasts. Natural plant derivatives and natural compounds have become major research hotspots for the treatment of osteolysis-related diseases due to their good safety profile and ability to improve bone. This paper provides an overview of recent advances in the molecular mechanisms of RANKL and downstream signaling pathways in osteoclast differentiation, and briefly outlines potential natural compounds with antiosteoclast activity and molecular mechanisms.<\/jats:p>","DOI":"10.3389\/fphar.2022.1043975","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T04:45:20Z","timestamp":1667969120000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Receptor activator of nuclear factor-\u03baB ligand-mediated osteoclastogenesis signaling pathway and related therapeutic natural compounds"],"prefix":"10.3389","volume":"13","author":[{"given":"Zechao","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingbo","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhe","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangcheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s00198-013-2313-x","article-title":"NF-\u03baB signaling and bone resorption","volume":"24","author":"Abu-Amer","year":"2013","journal-title":"Osteoporos. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"E3576","DOI":"10.3390\/ijms20143576","article-title":"Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases","volume":"20","author":"Agidigbi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.lfs.2016.01.024","article-title":"Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblast-mediated bone formation","volume":"147","author":"An","year":"2016","journal-title":"Life Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.3390\/jcm10133002","article-title":"The treatment gap in osteoporosis","volume":"10","author":"Ayub","year":"2021","journal-title":"J. Clin. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00223-017-0327-7","article-title":"Does oxidative stress play a role in altered characteristics of diabetic bone? A systematic review","volume":"101","author":"Bacevic","year":"2017","journal-title":"Calcif. Tissue Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"102022","DOI":"10.1016\/j.redox.2021.102022","article-title":"Protease-activated receptor 2 induces ROS-mediated inflammation through Akt-mediated NF-\u03baB and FoxO6 modulation during skin photoaging","volume":"44","author":"Bang","year":"2021","journal-title":"Redox Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet. Diabetes Endocrinol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1749-6632.2009.05315.x","article-title":"Functions of nuclear factor kappaB in bone","volume":"1192","author":"Boyce","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"664836","DOI":"10.3389\/fphar.2021.664836","article-title":"Notopterol attenuates estrogen deficiency-induced osteoporosis via repressing RANKL signaling and reactive oxygen species","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"8269","DOI":"10.1111\/jcmm.14700","article-title":"Asperpyrone A attenuates RANKL-induced osteoclast formation through inhibiting NFATc1, Ca(2+) signalling and oxidative stress","volume":"23","author":"Chen","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1152\/physrev.00012.2019","article-title":"Bone metastasis: mechanisms, therapies, and biomarkers","volume":"101","author":"Cl\u00e9zardin","year":"2021","journal-title":"Physiol. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fphar.2014.00120","article-title":"Osteoporosis and alzheimer pathology: Role of cellular stress response and hormetic redox signaling in aging and bone remodeling","volume":"5","author":"Cornelius","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.cell.2009.06.026","article-title":"SnapShot: Ca2+-calcineurin-NFAT signaling","volume":"138","author":"Crabtree","year":"2009","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.7861\/clinmedicine.16-4-360","article-title":"Recent advances in the pathogenesis and treatment of osteoporosis","volume":"16","author":"Curtis","year":"2016","journal-title":"Clin. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"675385","DOI":"10.3389\/fendo.2021.675385","article-title":"The role of osteoclast energy metabolism in the occurrence and development of osteoporosis","volume":"12","author":"Da","year":"2021","journal-title":"Front. Endocrinol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature10189","article-title":"Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis","volume":"475","author":"Denicola","year":"2011","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/jbmr.2986","article-title":"Lysosomal Ca(2+) signaling is essential for osteoclastogenesis and bone remodeling","volume":"32","author":"Erkhembaatar","year":"2017","journal-title":"J. Bone Min. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"118513","DOI":"10.1016\/j.lfs.2020.118513","article-title":"PI3K\/AKT\/mTOR signaling in gastric cancer: Epigenetics and beyond","volume":"262","author":"Fattahi","year":"2020","journal-title":"Life Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1056\/NEJMct1004903","article-title":"Bisphosphonates for osteoporosis","volume":"363","author":"Favus","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4248\/BR201301003","article-title":"Osteoclasts: New insights","volume":"1","author":"Feng","year":"2013","journal-title":"Bone Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1042\/CS20160897","article-title":"Redox theory of aging: implications for health and disease","volume":"131","author":"Go","year":"2017","journal-title":"Clin. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"813057","DOI":"10.3389\/fendo.2022.813057","article-title":"The role of NRF2 in bone metabolism - friend or foe?","volume":"13","author":"Han","year":"2022","journal-title":"Front. Endocrinol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"645140","DOI":"10.3389\/fphar.2021.645140","article-title":"Inhibitory effects of rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity","volume":"12","author":"He","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.3390\/cancers13102287","article-title":"AKT in bone metastasis of solid tumors: a comprehensive review","volume":"13","author":"Hinz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"E368","DOI":"10.3390\/nu11020368","article-title":"Beta-cryptoxanthin inhibits lipopolysaccharide-induced osteoclast differentiation and bone resorption via the suppression of inhibitor of NF-\u03baB kinase activity","volume":"11","author":"Hirata","year":"2019","journal-title":"Nutrients"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1002\/ctm2.392","article-title":"A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species","volume":"11","author":"Hong","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e52481","DOI":"10.15252\/embr.202152481","article-title":"RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss","volume":"22","author":"Hu","year":"2021","journal-title":"EMBO Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"E5841","DOI":"10.3390\/ijms20235841","article-title":"mTOR links tumor immunity and bone metabolism: What are the clinical implications?","volume":"20","author":"Irelli","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1021\/acs.jnatprod.9b01212","article-title":"Betulinic acid inhibits RANKL-induced osteoclastogenesis via attenuating Akt, NF-\u03baB, and PLC\u03b32-Ca(2+) signaling and prevents inflammatory bone loss","volume":"83","author":"Jeong","year":"2020","journal-title":"J. Nat. Prod."},{"key":"B32","doi-asserted-by":"publisher","first-page":"E1636","DOI":"10.3390\/cells8121636","article-title":"The role of NF-\u03baB in physiological bone development and inflammatory bone diseases: Is NF-\u03baB inhibition \"killing two birds with one stone?","volume":"8","author":"Jimi","year":"2019","journal-title":"Cells"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1002\/jcp.29968","article-title":"Cinchonine inhibits osteoclast differentiation by regulating TAK1 and AKT, and promotes osteogenesis","volume":"236","author":"Jo","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.mcna.2020.06.004","article-title":"Osteoporosis in older adults","volume":"104","author":"Johnston","year":"2020","journal-title":"Med. Clin. North Am."},{"key":"B35","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/978-94-007-2888-2_41","article-title":"Calcium signaling in osteoclast differentiation and bone resorption","volume":"740","author":"Kajiya","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"E3646","DOI":"10.3390\/ijms21103646","article-title":"The role of Ca(2+)-NFATc1 signaling and its modulation on osteoclastogenesis","volume":"21","author":"Kang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1058","DOI":"10.1371\/journal.pone.0001058","article-title":"Akt1 in osteoblasts and osteoclasts controls bone remodeling","volume":"2","author":"Kawamura","year":"2007","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"E2073","DOI":"10.3390\/cells9092073","article-title":"Osteoblast-osteoclast communication and bone homeostasis","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"key":"B39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bone.2013.12.013","article-title":"Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLC\u03b32-Ca(2+)-NFATc1 signaling, and suppresses bone loss in mice","volume":"60","author":"Kim","year":"2014","journal-title":"Bone"},{"key":"B40","doi-asserted-by":"publisher","first-page":"E5685","DOI":"10.3390\/ijms21165685","article-title":"Osteoclast multinucleation: Review of current literature","volume":"21","author":"Kodama","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1111\/jcmm.15052","article-title":"Integrin-associated molecules and signalling cross talking in osteoclast cytoskeleton regulation","volume":"24","author":"Kong","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrendo.2011.108","article-title":"Parathyroid hormone analogues in the treatment of osteoporosis","volume":"7","author":"Kraenzlin","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.7150\/ijbs.13814","article-title":"Selective regulation of MAPK signaling mediates RANKL-dependent osteoclast differentiation","volume":"12","author":"Lee","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"E3004","DOI":"10.3390\/ijms19103004","article-title":"Roles of mitogen-activated protein kinases in osteoclast biology","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1111\/jcmm.16430","article-title":"Galangin suppresses RANKL-induced osteoclastogenesis via inhibiting MAPK and NF-\u03baB signalling pathways","volume":"25","author":"Li","year":"","journal-title":"J. Cell. Mol. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.drudis.2021.03.002","article-title":"Targeting reactive oxygen species in stem cells for bone therapy","volume":"26","author":"Li","year":"","journal-title":"Drug Discov. Today"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1080\/21691401.2019.1637881","article-title":"The efficacy and potential mechanism of cnidium lactone to inhibit osteoclast differentiation","volume":"47","author":"Liang","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/jcp.29948","article-title":"Inhibitory effects of biochanin A on titanium particle-induced osteoclast activation and inflammatory bone resorption via NF-\u03baB and MAPK pathways","volume":"236","author":"Liao","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(18)30754-2","article-title":"Teriparatide vs risedronate for osteoporosis","volume":"391","author":"Liel","year":"2018","journal-title":"Lancet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"796227","DOI":"10.3389\/fcell.2022.796227","article-title":"Acacetin prevents bone loss by disrupting osteoclast formation and promoting type H vessel formation in ovariectomy-induced osteoporosis","volume":"10","author":"Lin","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"152520","DOI":"10.1016\/j.tox.2020.152520","article-title":"Ca(2+)\/CaM\/CaMK signaling is involved in cadmium-induced osteoclast differentiation","volume":"441","author":"Liu","year":"2020","journal-title":"Toxicology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.7150\/thno.35414","article-title":"Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities","volume":"9","author":"Liu","year":"2019","journal-title":"Theranostics"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1172\/JCI94606","article-title":"The many ways of osteoclast activation","volume":"127","author":"Lorenzo","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/jcmm.13066","article-title":"Baicalin positively regulates osteoclast function by activating MAPK\/Mitf signalling","volume":"21","author":"Lu","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"101678","DOI":"10.1016\/j.redox.2020.101678","article-title":"Interrelation between ROS and Ca(2+) in aging and age-related diseases","volume":"36","author":"Madreiter-Sokolowski","year":"2020","journal-title":"Redox Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1210\/en.2009-0026","article-title":"Phosphatidylinositol 3 kinase\/Akt signal relay cooperates with smad in bone morphogenetic protein-2-induced colony stimulating factor-1 (CSF-1) expression and osteoclast differentiation","volume":"150","author":"Mandal","year":"2009","journal-title":"Endocrinology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.cell.2021.03.010","article-title":"Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption","volume":"184","author":"Mcdonald","year":"2021","journal-title":"Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"17660","DOI":"10.1074\/jbc.M311032200","article-title":"Src kinase activity is essential for osteoclast function","volume":"279","author":"Miyazaki","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4049\/jimmunol.1101254","article-title":"Akt induces osteoclast differentiation through regulating the GSK3\u03b2\/NFATc1 signaling cascade","volume":"188","author":"Moon","year":"2012","journal-title":"J. Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-\u03baB signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0014-5793(95)00153-z","article-title":"Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption","volume":"361","author":"Nakamura","year":"1995","journal-title":"FEBS Lett."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e12882","DOI":"10.1111\/cpr.12882","article-title":"Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling","volume":"53","author":"Ni","year":"2020","journal-title":"Cell Prolif."},{"key":"B64","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/cr.2010.159","article-title":"Role of NF-\u03baB in the skeleton","volume":"21","author":"Novack","year":"2011","journal-title":"Cell Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1600-0765.2006.00959.x","article-title":"Mitogen-activated protein kinases mediate interleukin-1beta-induced receptor activator of nuclear factor-kappaB ligand expression in human periodontal ligament cells","volume":"42","author":"Oikawa","year":"2007","journal-title":"J. Periodontal Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"E180","DOI":"10.3390\/ijms22010180","article-title":"Finely-tuned calcium oscillations in osteoclast differentiation and bone resorption","volume":"22","author":"Okada","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"118681","DOI":"10.1016\/j.lfs.2020.118681","article-title":"Effects of bisphosphonates on osteoporosis: Focus on zoledronate","volume":"264","author":"Oryan","year":"2021","journal-title":"Life Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.2147\/DDDT.S270829","article-title":"A review on the role of denosumab in fracture prevention","volume":"14","author":"Pang","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"B69","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2174\/1871530319666190204165207","article-title":"Biomarkers of osteoporosis: an update","volume":"19","author":"Parveen","year":"2019","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"B70","doi-asserted-by":"publisher","first-page":"115048","DOI":"10.1016\/j.bone.2019.115048","article-title":"Off-label uses of denosumab in metabolic bone diseases","volume":"129","author":"Polyzos","year":"2019","journal-title":"Bone"},{"key":"B71","doi-asserted-by":"publisher","first-page":"108113","DOI":"10.1016\/j.intimp.2021.108113","article-title":"Anethole inhibits RANKL-induced osteoclastogenesis by downregulating ERK\/AKT signaling and prevents ovariectomy-induced bone loss in vivo","volume":"100","author":"Qu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1111\/jcmm.17467","article-title":"Urolithin B suppresses osteoclastogenesis via inhibiting RANKL-induced signalling pathways and attenuating ROS activities","volume":"26","author":"Qu","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","article-title":"Drug therapy for osteoporosis in older adults","volume":"399","author":"Reid","year":"2022","journal-title":"Lancet"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e13122","DOI":"10.1111\/cpr.13122","article-title":"The role of Ca(2+) \/Calcineurin\/NFAT signalling pathway in osteoblastogenesis","volume":"54","author":"Ren","year":"2021","journal-title":"Cell Prolif."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00198-020-05497-8","article-title":"Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?","volume":"31","author":"Rozenberg","year":"2020","journal-title":"Osteoporos. Int."},{"key":"B77","doi-asserted-by":"publisher","first-page":"101845","DOI":"10.1016\/j.redox.2020.101845","article-title":"NRF2 function in osteocytes is required for bone homeostasis and drives osteocytic gene expression","volume":"40","author":"S\u00e1nchez-De-Diego","year":"2021","journal-title":"Redox Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2106\/JBJS.F.00615","article-title":"Inhibition of the PI3K-Akt signaling pathway reduces tumor necrosis factor-alpha production in response to titanium particles in vitro","volume":"89","author":"Smith","year":"2007","journal-title":"J. Bone Jt. Surg. Am."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1359\/jbmr.2000.15.8.1477","article-title":"Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts","volume":"15","author":"Takeshita","year":"2000","journal-title":"J. Bone Min. Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"637","DOI":"10.14336\/AD.2018.0513","article-title":"The anti-inflammatory and anti-oxidant mechanisms of the keap1\/nrf2\/ARE signaling pathway in chronic diseases","volume":"10","author":"Tu","year":"2019","journal-title":"Aging Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","article-title":"Osteoclast differentiation by RANKL and OPG signaling pathways","volume":"39","author":"Udagawa","year":"2021","journal-title":"J. Bone Min. Metab."},{"key":"B82","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.drudis.2013.08.010","article-title":"Is bisphosphonate therapy compromised by the emergence of adverse bone disorders?","volume":"19","author":"Verron","year":"2014","journal-title":"Drug Discov. Today"},{"key":"B83","doi-asserted-by":"publisher","first-page":"729909","DOI":"10.3389\/fphar.2021.729909","article-title":"Induction of PI3K\/Akt-Mediated apoptosis in osteoclasts is a key approach for buxue tongluo pills to treat osteonecrosis of the femoral head","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"878433","DOI":"10.3389\/fcell.2022.878433","article-title":"Tanshinone ameliorates glucocorticoid-induced bone loss via activation of AKT1 signaling pathway","volume":"10","author":"Wang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e3198","DOI":"10.1002\/jgm.3198","article-title":"Cnidium lactone prevents bone loss in an ovariectomized rat model through the estrogen-\u03b1\/BMP-2\/Smad signaling pathway","volume":"22","author":"Wang","year":"2020","journal-title":"J. Gene Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"106400","DOI":"10.1016\/j.phrs.2022.106400","article-title":"Alpinetin ameliorates bone loss in LPS-induced inflammation osteolysis via ROS mediated P38\/PI3K signaling pathway","volume":"184","author":"Wei","year":"2022","journal-title":"Pharmacol. Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJMc0808738","article-title":"Reports of esophageal cancer with oral bisphosphonate use","volume":"360","author":"Wysowski","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"114761","DOI":"10.1016\/j.bcp.2021.114761","article-title":"Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation","volume":"193","author":"Xian","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"21706","DOI":"10.18632\/aging.103976","article-title":"Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6\/ROS-dependent MAPK\/NF-\u03baB signaling pathways","volume":"12","author":"Xiao","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B90","doi-asserted-by":"publisher","first-page":"112873","DOI":"10.1016\/j.jep.2020.112873","article-title":"A natural compound (LCA) isolated from Litsea cubeba inhibits RANKL-induced osteoclast differentiation by suppressing Akt and MAPK pathways in mouse bone marrow macrophages","volume":"257","author":"Yu","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41401-019-0289-6","article-title":"Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4\/TRAF6 and PLC\u03b31-Ca(2+)-NFATc1 signaling pathway","volume":"41","author":"Zeng","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"B92","doi-asserted-by":"publisher","first-page":"112170","DOI":"10.1016\/j.biopha.2021.112170","article-title":"MAPK \/ERK signaling pathway: A potential target for the treatment of intervertebral disc degeneration","volume":"143","author":"Zhang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B93","doi-asserted-by":"publisher","first-page":"4350965","DOI":"10.1155\/2016\/4350965","article-title":"ROS and ROS-mediated cellular signaling","volume":"2016","author":"Zhang","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B94","doi-asserted-by":"publisher","first-page":"898634","DOI":"10.3389\/fendo.2022.898634","article-title":"Autophagy in bone remodeling: A regulator of oxidative stress","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Endocrinol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"109769","DOI":"10.1016\/j.biopha.2019.109769","article-title":"Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss","volume":"123","author":"Zhu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B96","doi-asserted-by":"publisher","first-page":"153377","DOI":"10.1016\/j.phymed.2020.153377","article-title":"Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca(2+)-NFATc1 and Cav-1 signaling pathways","volume":"80","author":"Zou","year":"2021","journal-title":"Phytomedicine"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1043975\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T04:45:25Z","timestamp":1667969125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1043975\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":96,"alternative-id":["10.3389\/fphar.2022.1043975"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1043975","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"article-number":"1043975"}}